Cargando…

Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

Long-chain omega-3 polyunsaturated fatty acids (PUFAs) are essential for neural development and function. As key components of brain tissue, omega-3 PUFAs play critical roles in brain development and function, and a lack of these fatty acids has been implicated in a number of mental health condition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amminger, G. Paul, Schäfer, Miriam R., Schlögelhofer, Monika, Klier, Claudia M., McGorry, Patrick D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918317/ https://www.ncbi.nlm.nih.gov/pubmed/26263244 http://dx.doi.org/10.1038/ncomms8934

Ejemplares similares

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study
por: Kim, Sung-Wan, et al.
Publicado: (2016)

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study
por: Berger, M E, et al.
Publicado: (2017)

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
por: Föcking, Melanie, et al.
Publicado: (2016)

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course
por: Nelson, B., et al.
Publicado: (2018)

Erythrocyte glutathione levels as long-term predictor of transition to psychosis
por: Lavoie, S, et al.
Publicado: (2017)

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
por: Amminger, G P, et al.
Publicado: (2015)

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis
por: Berger, Gregor E., et al.
Publicado: (2016)

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS
por: Paul Amminger, G, et al.
Publicado: (2018)

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research
por: Nelson, Barnaby, et al.
Publicado: (2018)

F130. INCREASED RISK OF PSYCHOTIC DISORDERS IN AFRICAN MIGRANTS TO AUSTRALIA
por: Downey, Linglee, et al.
Publicado: (2018)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

Gender differences in first episode psychotic mania
por: Cotton, Sue M, et al.
Publicado: (2013)

Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
por: Cheng, Nicholas, et al.
Publicado: (2022)

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence
por: Mongan, David, et al.
Publicado: (2021)

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL
por: Allott, Kelly, et al.
Publicado: (2018)

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers
por: Clark, S R, et al.
Publicado: (2016)

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids
por: Vijayakumar, Nandita, et al.
Publicado: (2016)

Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis
por: Susai, Subash Raj, et al.
Publicado: (2022)

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2018)

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION
por: Schlögelhofer, Monika, et al.
Publicado: (2018)

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate
por: Shrivastava, Amresh, et al.
Publicado: (2011)

Omega-3 and Omega-6 fatty acids and risk of psychotic outcomes in the ALSPAC birth cohort
por: Thompson, A.D., et al.
Publicado: (2020)

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING
por: Yuen, Hok Pan, et al.
Publicado: (2018)

T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL
por: Schlögelhofer, Monika, et al.
Publicado: (2020)

Early Intervention in Psychosis: Obvious, Effective, Overdue
por: McGorry, Patrick D.
Publicado: (2015)

The reality of mental health care for young people, and the urgent need for solutions
por: McGorry, Patrick D
Publicado: (2021)

Empirically driven transdiagnostic stages in the development of mood, anxiety and psychotic symptoms in a cohort of youth followed from birth
por: Ratheesh, Aswin, et al.
Publicado: (2023)

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY
por: Berger, Maximus, et al.
Publicado: (2018)

O10.8. A PLURIPOTENTIAL AT RISK MENTAL STATE: INITIAL RESULTS
por: Hartmann, Jessica A, et al.
Publicado: (2018)

Important aspects in the assessment of bilingual children with suspected language impairment: The Vienna Model
por: Eisenwort, Brigitte, et al.
Publicado: (2020)

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis
por: Mechelli, Andrea, et al.
Publicado: (2017)

M22. IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2020)

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
por: Berger, Maximus, et al.
Publicado: (2019)

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
por: Berger, Maximus, et al.
Publicado: (2020)

Delayed sleep onset in depressed young people
por: Glozier, Nicholas, et al.
Publicado: (2014)

Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders
por: Yoo, Taeyoung, et al.
Publicado: (2018)

T159. ASSOCIATION BETWEEN VITAMIN D INSUFFICIENCY AND METABOLIC SYNDROME IN PATIENTS WITH PSYCHOTIC DISORDERS
por: Kim, Sung-Wan, et al.
Publicado: (2018)

Prevalence of Comorbid Personality Disorder in Psychotic and Non-psychotic Disorders
por: Wang, Qiang, et al.
Publicado: (2021)

Vienna Conference
Publicado: (1968)

From Vienna
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_bdsp2gt31ja8cpq5jkufdql900